News

Glaxosmithkline, with multiple operations in Montco, just scored a major regulatory win that could reshape how lupus ...
Dr. Richard Philipson has been appointed Chief Medical Officer (CMO) of Hansa Biopharma AB, effective July 14.
Hansa Biopharma AB, "Hansa" (NASDAQ Stockholm: HNSA) today announced that Dr. Richard Philipson has been appointed Chief Medical Officer (CMO) effective 14 July. Dr Philipson will report to CEO Renée ...
The National Pharmaceutical Pricing Authority (NPPA) has notified the separate retail price of GlaxoSmithKline (GSK) Asia's cold medicine combination paracetamol 500 mg and phenylephrine HCl 10 mg at ...
The Lung Association's Living Well with COPD campaign provides free one-on-one COPD support, education and resources tailored for every stage of the disease. The campaign is created for all families ...
Hansa Biopharma AB, "Hansa" (NASDAQ Stockholm: HNSA) today announced that Dr. Richard Philipson has been appointed Chief Medical Officer (CMO) effective ...
The U.S. Centers for Disease Control and Prevention has ended its emergency response to the H5N1 bird flu outbreak, a move ...
Glaxosmithkline Pharmaceutical is trading -0.12 % lower at Rs 3,281.65 as compared to its last closing price. Glaxosmithkline Pharmaceutical has been trading in the price range of 3,356.00 & 3,271.45.
GSK has concluded the acquisition of efimosfermin alfa, an investigational therapeutic for serious liver disease (SLD), from ...
GSK PLC closed 15.77% below its 52-week high of £16.79, which the company reached on September 9th.
Novartis and a Swiss nonprofit have made history, scoring the world’s first approval for a medicine to treat babies who are ...
Single-cell RNA-seq (scRNA-seq) has spent the past decade maturing into a foundational technology. Over that time, the ...